NRx Pharmaceuticals Stock Forecast, Price & News

NRx Pharmaceuticals (NASDAQ:NRXP) Frequently Asked Questions

Are investors shorting NRx Pharmaceuticals?

NRx Pharmaceuticals saw a decrease in short interest in November. As of November 15th, there was short interest totaling 1,180,000 shares, a decrease of 29.3% from the October 31st total of 1,670,000 shares. Based on an average trading volume of 2,740,000 shares, the short-interest ratio is presently 0.4 days. Approximately 5.1% of the shares of the company are short sold.
View NRx Pharmaceuticals' Short Interest.

When is NRx Pharmaceuticals' next earnings date?

NRx Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, February 15th 2022.
View our earnings forecast for NRx Pharmaceuticals.

How were NRx Pharmaceuticals' earnings last quarter?

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) announced its quarterly earnings results on Tuesday, November, 16th. The company reported ($0.39) earnings per share for the quarter.
View NRx Pharmaceuticals' earnings history.

Who are NRx Pharmaceuticals' key executives?

NRx Pharmaceuticals' management team includes the following people:

• Jonathan C. Javitt, Chairman & Chief Executive Officer
• Robert Besthof, Chief Commercial & Patent Officer, Head-Operations (LinkedIn Profile)
• James Brandon, Chief Financial Officer
• Dennis K. McBride, Chief Strategy Officer
• Randy Guggenheimer, Chief Business Officer

Who are some of NRx Pharmaceuticals' key competitors?

Some companies that are related to NRx Pharmaceuticals include Amarin (AMRN), NGM Biopharmaceuticals (NGM), ImmunoGen (IMGN), FibroGen (FGEN), Organogenesis (ORGO), Xenon Pharmaceuticals (XENE), Madrigal Pharmaceuticals (MDGL), MorphoSys (MOR), uniQure (QURE), Keros Therapeutics (KROS), Axsome Therapeutics (AXSM), ALX Oncology (ALXO), Amneal Pharmaceuticals (AMRX), Nurix Therapeutics (NRIX) and Prometheus Biosciences (RXDX).
View all of NRXP's competitors.

What is NRx Pharmaceuticals' stock symbol?

NRx Pharmaceuticals trades on the NASDAQ under the ticker symbol "NRXP."

Who are NRx Pharmaceuticals' major shareholders?

NRx Pharmaceuticals' stock is owned by a number of institutional and retail investors. Top institutional investors include Citadel Advisors LLC (0.00%), Cambridge Investment Research Advisors Inc. (0.29%), Geode Capital Management LLC (0.09%), Jane Street Group LLC (0.00%), Advisor Group Holdings Inc. (0.08%) and Wolverine Asset Management LLC (0.08%). Company insiders that own NRx Pharmaceuticals stock include Alessandra Daigneault and Robert Besthof.
View institutional ownership trends for NRx Pharmaceuticals.

Which major investors are buying NRx Pharmaceuticals stock?

NRXP stock was purchased by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Cambridge Investment Research Advisors Inc., Jane Street Group LLC, Advisor Group Holdings Inc., Wolverine Asset Management LLC, Geode Capital Management LLC, Penserra Capital Management LLC, and Clear Street Markets LLC.
View insider buying and selling activity for NRx Pharmaceuticals or or view top insider-buying stocks.

How do I buy shares of NRx Pharmaceuticals?

Shares of NRXP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NRx Pharmaceuticals' stock price today?

One share of NRXP stock can currently be purchased for approximately $6.21.

How much money does NRx Pharmaceuticals make?

NRx Pharmaceuticals has a market capitalization of $365.21 million.

How many employees does NRx Pharmaceuticals have?

NRx Pharmaceuticals employs 2 workers across the globe.

What is NRx Pharmaceuticals' official website?

The official website for NRx Pharmaceuticals is www.bigrockpartners.com.

Where are NRx Pharmaceuticals' headquarters?

NRx Pharmaceuticals is headquartered at 2645 N. Federal Highway Suite 230, Delray Beach FL, 33483.

How can I contact NRx Pharmaceuticals?

NRx Pharmaceuticals' mailing address is 2645 N. Federal Highway Suite 230, Delray Beach FL, 33483. The company can be reached via phone at (484) 254-6134.